When combined with baseline metabolic data and your medical history, genetic insights can support a more personalized conversation with your provider about whether berberine-GLP-1 combinations, GLP-1 monotherapy through PlexusDx's compounded semaglutide or tirzepatide options, or other metabolic interventions represent the most evidence-aligned choice for your individual circumstances
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, not specifically for insulin resistance alone
Amennyiben ezek brmelyike fennll a betegnl, elszr azt kell kezelni, rendezni, msklnben fennll a kockzat, hogy mg ha sikerl is rdemi fogyst elrni, az nem bizonyul majd tartsnak
If you are pregnant or find out you are pregnant while taking one, the guidance is to stop the medication and contact your clinician promptly
Below is a clear, evidence-based comparison written for patients across Northwest Louisiana who want to understand their options before making a decision